Next Generation Antidepressants

Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

Nonfiction, Health & Well Being, Medical, Specialties, Psychiatry, Ailments & Diseases, Mental Health
Cover of the book Next Generation Antidepressants by , Cambridge University Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781139833448
Publisher: Cambridge University Press Publication: May 20, 2010
Imprint: Cambridge University Press Language: English
Author:
ISBN: 9781139833448
Publisher: Cambridge University Press
Publication: May 20, 2010
Imprint: Cambridge University Press
Language: English

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

More books from Cambridge University Press

Cover of the book Dynamics of Particles and Rigid Bodies by
Cover of the book Mental Disorders Around the World by
Cover of the book Europe's Future by
Cover of the book A Dictionary of Bible Plants by
Cover of the book Law, Text, Terror by
Cover of the book Literacy in Early Childhood and Primary Education by
Cover of the book Patronal Politics by
Cover of the book Proving Bribery, Fraud and Money Laundering in International Arbitration by
Cover of the book The Cambridge Companion to Caryl Churchill by
Cover of the book Globalization in Prehistory by
Cover of the book Principles of Biomedical Instrumentation by
Cover of the book The Judicial Assessment of Expert Evidence by
Cover of the book The Politics of Sacrifice in Early Greek Myth and Poetry by
Cover of the book Defeating Authoritarian Leaders in Postcommunist Countries by
Cover of the book The Cambridge Companion to Atheism by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy